Mapping of HPV transcripts in four human cervical lesions using RNAseq suggests quantitative rearrangements during carcinogenic progression

Virology

Volumn 462-463, Issue 1, 2014, Pages 14-24

  Chen, Jinmiao ^a   Xue, Yuezhen ^b   Poidinger, Michael ^a   Lim, Thimothy ^c   Chew, Sung Hock ^c   Pang, Chai Ling ^a   Abastado, Jean Pierre ^a   Thierry, Françoise ^b  

^a AGENCY FOR SCIENCE   (Singapore)

^b INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^c KK Hospital   (Singapore)

Author keywords

Carcinogenesis; HPV; Patient samples; Promoter usage; Quantification; RNAseq; Transcripts

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E5; GLYCOPROTEIN E1; GLYCOPROTEIN E2; PROTEIN E7; TRANSCRIPTOME;

ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CARCINOGENESIS; CONDYLOMA; CONTROLLED STUDY; GENE MAPPING; GENE REARRANGEMENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 6B; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RNA SEQUENCE; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CHARACTERIZATION; VIRUS GENOME; VIRUS TRANSCRIPTION;

CARCINOGENESIS; HPV; PATIENT SAMPLES; PROMOTER USAGE; QUANTIFICATION; RNASEQ; TRANSCRIPTS;

CELL TRANSFORMATION, VIRAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 84902289406     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.05.026     Document Type: Article

References (51)

1. Arron S.T., Ruby J.G., Dybbro E., Ganem D., Derisi J.L. Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma. J. Invest. Dermatol. 2011, 131:1745-1753.
2. Ben Khalifa Y., Teissier S., Tan M.K., Phan Q.T., Daynac M., et al. The human papillomavirus E6 oncogene represses a cell adhesion pathway and disrupts focal adhesion through degradation of TAp63beta upon transformation. PLoS Pathog. 2011, 7:e1002256.
3. Baker C.C., Phelps W.C., Lindgren V., Braun M.J., Gonda M.A., et al. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 1987, 61:962-971.
4. Bedell M.A., Hudson J.B., Golub T.R., Turyk M.E., Hosken M., et al. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J. Virol. 1991, 65:2254-2260.
5. Baker, C.C., Calef, C., 1996. Maps of Papillomavirus mRNA Transcripts; Laboratory LAN. Los Alamos National Laboratory, NM.
6. Bernard H.U., Burk R.D., Chen Z., van Doorslaer K., zur Hausen H., et al. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401:70-79.
7. Bohm S., Wilczynski S.P., Pfister H., Iftner T. The predominant mRNA class in HPV16-infected genital neoplasias does not encode the E6 or the E7 protein. Int. J. Cancer 1993, 55:791-798.
8. Chatterjee S., Pal J.K. Role of 5'- and 3'-untranslated regions of mRNAs in human diseases. Biol. Cell 2009, 101:251-262.
9. Chow L.T., Nasseri M., Wolinsky S.M., Broker T.R. Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata. J. Virol. 1987, 61:2581-2588.
10. Doorbar J., Parton A., Hartley K., Banks L., Crook T., et al. Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. Virology 1990, 178:254-262.
11. Das Ghosh D., Bhattacharjee B., Sen S., Premi L., Mukhopadhyay I., et al. Some novel insights on HPV16 related cervical cancer pathogenesis based on analyses of LCR methylation, viral load, E7 and E2/E4 expressions. PLoS One 2012, 7:e44678.
12. Doorbar J. The papillomavirus life cycle. J. Clin. Virol. 2005, 32(Suppl. 1):S7-S15.
13. Doorbar J., Campbell D., Grand R.J., Gallimore P.H. Identification of the human papilloma virus-1a E4 gene products. EMBO J. 1986, 5:355-362.
14. Doorbar J., Elston R.C., Napthine S., Raj K., Medcalf E., et al. The E1E4 protein of human papillomavirus type 16 associates with a putative RNA helicase through sequences in its C terminus. J. Virol. 2000, 74:10081-10095.
15. Dong G., Broker T.R., Chow L.T. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J. Virol. 1994, 68:1115-1127.
16. Gray E., Pett M.R., Ward D., Winder D.M., Stanley M.A., et al. in vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis. Cancer Res. 2010, 70:4081-4091.
17. Ge H., Liu K., Juan T., Fang F., Newman M., et al. FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution. Bioinformatics 2011, 27:1922-1928.
18. Grassmann K., Rapp B., Maschek H., Petry K.U., Iftner T. Identification of a differenciation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J. Virol. 1996, 70:2339-2349.
19. Howie H.L., Katzenellenbogen R.A., Galloway D.A. Papillomavirus E6 proteins. Virology 2009, 384:324-334.
20. Kalantari M., Osann K., Calleja-Macias I.E., Kim S., Yan B., et al. Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: considerations for use as biomarkers of the progression of cervical neoplasia. Virology 2014, 448:314-321.
21. Khoury J.D., Tannir N.M., Williams M.D., Chen Y., Yao H., et al. Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J. Virol. 2013, 87:8916-8926.
22. Langmead B., Salzberg S.L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 2012, 9:357-359.
23. Lai D., Tan C.L., Gunaratne J., Quek L.S., Nei W., et al. Localization of HPV-18 E2 at mitochondrial membranes induces ROS release and modulates host cell metabolism. PLoS One 2013, 8:e75625.
24. Li Y., Wang X., Ni T., Wang F., Lu W., et al. Human papillomavirus type 58 genome variations and RNA expression in cervical lesions. J. Virol. 2013, 87:9313-9322.
25. Munger K., Howley P.M. Human papillomavirus immortalization and transformation functions. Virus Res. 2002, 89:213-228.
26. McLaughlin-Drubin M.E., Munger K. The human papillomavirus E7 oncoprotein. Virology 2009, 384:335-344.
27. Milligan S.G., Veerapraditsin T., Ahamet B., Mole S., Graham S.V. Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells. Virology 2007, 360:172-181.
28. Nicol J.W., Helt G.A., Blanchard S.G., Raja A., Loraine A.E. The Integrated Genome Browser: free software for distribution and exploration of genome-scale datasets. Bioinformatics 2009, 25:2730-2731.
29. Nilsson C.H., Bakos E., Petry K.U., Schneider A., Durst M. Promoter usage in the E7 ORF of HPV16 correlates with epithelial differentiation and is largely confined to low-grade genital neoplasia. Int. J. Cancer 1996, 65:6-12.
30. Romanczuk H., Thierry F., Howley P.M. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J. Virol. 1990, 64:2849-2859.
31. Renaud K.J., Cowsert L.M. Characterization of human papillomavirus-11 mRNAs expressed in the context of autonomously replicating viral genomes. Virology 1996, 220:177-185.
32. Schwarz E., Sneider-Gädicke A., Roggenbuck B., Mayer W., Gissman L. Expression of human papillomavirus DNA in cervical carcinoma cell lines. Banburry Rep. 1986, 21:281-290.
33. Schwarz E., Freese U.K., Gissmann L., Mayer W., Roggenbuck B., et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985, 314:111-114.
34. Seedorf K., Oltersdorf T., Krämmer G., Röwenkamp W. Identification of early proteins of the human papillomavirus type 16 (HPV16) and type 18 (HPV18) in cervical carcinoma cells. EMBO J. 1987, 6:139-144.
35. Smotkin D., Wettstein F.O. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc. Natl. Acad. Sci. USA 1986, 83:4680-4684.
36. Schmitt M., Dalstein V., Waterboer T., Clavel C., Gissmann L., et al. The HPV16 transcriptome in cervical lesions of different grades. Mol. Cell. Probes 2011, 25:260-265.
37. Smotkin D., Prokoph H., Wettstein F.O. Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J. Virol. 1989, 63:1441-1447.
38. Sahab Z., Sudarshan S.R., Liu X., Zhang Y., Kirilyuk A., et al. Quantitative measurement of human papillomavirus type 16 e5 oncoprotein levels in epithelial cell lines by mass spectrometry. J. Virol. 2012, 86:9465-9473.
39. Sherman L., Alloul N., Golan I., Durst M., Baram A. Expression and splicing patterns of human papillomavirus type-16 mRNAs in pre-cancerous lesions and carcinomas of the cervix, in human keratinocytes immortalized by HPV 16, and in cell lines established from cervical cancers. Int. J. Cancer 1992, 50:356-364.
40. Stoler M.H., Rhodes C.R., Whitbeck A., Wolinsky S.M., Chow L.T., et al. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum. Pathol. 1992, 23:117-128.
41. Stoler M.H., Wolinsky S.M., Whitbeck A., Broker T.R., Chow L.T. Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 1989, 172:331-340.
42. Trapnell C., Pachter L., Salzberg S.L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009, 25:1105-1111.
43. Trapnell C., Williams B.A., Pertea G., Mortazavi A., Kwan G., et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 2010, 28:511-515.
44. Thierry F. Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology 2009, 384:375-379.
45. Venuti A., Paolini F., Nasir L., Corteggio A., Roperto S., et al. Papillomavirus E5: the smallest oncoprotein with many functions. Mol. Cancer 2011, 10:140.
46. Vinokurova S., von Knebel Doeberitz M. Differential methylation of the HPV 16 upstream regulatory region during epithelial differentiation and neoplastic transformation. PLoS One 2011, 6:e24451.
47. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189:12-19.
48. Wang X., Meyers C., Wang H.K., Chow L.T., Zheng Z.M. Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J. Virol. 2011, 85:8080-8092.
49. Xue Y., Bellanger S., Zhang W., Lim D., Low J., et al. HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma. Cancer Res. 2010, 70:5316-5325.
50. Xue Y., Lim D., Zhi L., He P., Abastado J.P., et al. Loss of HPV16 E2 protein expression without disruption of the E2 ORF correlates with carcinogenic progression. Open Virol. J. 2012, 6:163-172.
51. Zheng Z.M., Baker C.C. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front. Biosci. 2006, 11:2286-2302.